Literature DB >> 17282689

Interleukin-2 Improves Vascular Functions in Streptozotocin-induced Diabetic Rats.

Lingbo Qian1, Huiping Wang, Qiang Xia, Iain Bruce, He Huang.   

Abstract

To investigate changes in vascular functions in streptozotocin (STZ)-induced diabetic rats and the effect of interleukin-2 (IL-2), male Sprague-Dawley rats were randomly divided into a normal group, a diabetic control group, and diabetic groups treated with a low dose (5000 U/kg/d) or a high dose of IL-2 (50000 U/kg/d) for five weeks. Rats were injected with STZ (60 mg/kg, i.p.) to induce diabetes. The contractions in response to KCl, phenylephrine (PE), and CaCl<sub>2</sub>, and the vasorelaxant effect of acetylcholine (ACh) on rings from thoracic aortae preconstricted with PE were determined using organ bath technique. In the diabetic group, the contractile responses to PE were significantly impaired. Treatment with IL-2 improved this response, but the high dose was less effective. However, IL-2 attenuated the contractile response to KCl in the diabetic groups in a dose-dependent manner. The high concentration of IL-2 decreased the contractile response to CaCl<sub>2</sub>. ACh caused a dose-dependent relaxation of aortic rings that was impaired in the diabetic group. The vascular responses in IL-2 treated groups were preserved. The results indicate that IL-2 can improve vascular function in diabetic rat.

Entities:  

Year:  2005        PMID: 17282689     DOI: 10.1109/IEMBS.2005.1616920

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  2 in total

1.  Propolis protects against high glucose-induced vascular endothelial dysfunction in isolated rat aorta.

Authors:  Mohammed S El-Awady; Dina S El-Agamy; Ghada M Suddek; Manar A Nader
Journal:  J Physiol Biochem       Date:  2013-11-15       Impact factor: 4.158

2.  Effects of high glucose with or without other metabolic substrates on alpha-adrenergic contractions in rat mesenteric and femoral arteries.

Authors:  Rany Vorn; Hae Young Yoo
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.